カテゴリー： QYResearch, 世界, 部品/材料

世界のフェロジピン市場インサイト及び予測（純度98％、純度99％）

◆英語タイトル：Global Felodipine Market Insights, Forecast to 2028
	◆商品コード：QY22JL0369 ◆発行会社（リサーチ会社）：QYResearch ◆発行日：2022年7月（※2025年版があります。お問い合わせください。） ◆ページ数：91 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後3営業日） ◆調査対象地域：グローバル ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥705,600	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,058,400	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,411,200	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

フェロジピン（Felodipine）はカルシウム拮抗薬の一種であり、高血圧や狭心症の治療に用いられる代表的な薬剤です。ここでは、フェロジピンの定義、特徴、用途、関連技術などについて、詳細にご説明いたします。

フェロジピンは、主に血管平滑筋に作用し、血管の弛緩を促進することによって血圧を低下させる機序を持っています。この薬剤は、ジヒドロピリジン系カルシウム拮抗薬に分類されており、特に血管に強い選択性を示します。そのため、心臓への負荷を軽減し、狭心症の症状を和らげる効果も期待されます。

フェロジピンの特徴の一つとして、半減期が比較的長いことが挙げられます。通常、服用後約11時間から13時間の間に血中濃度が半減します。このため、日1回の服用で高い治療効果を維持することが可能です。また、フェロジピンは食事の影響を受けにくく、通常のふつうの食事と一緒に服用しても、効果に大きな差が出ないことが特徴です。

フェロジピンは、通常は経口投与され、直接的な作用によって高血圧をコントロールします。具体的には、血管平滑筋に存在するカルシウムチャネルを阻害し、カルシウムの流入を抑制することで、筋肉の収縮を抑え、血管を拡張させる作用を持ちます。その結果、血圧が低下し、心臓にかかる負担も軽減されます。

医療現場では、フェロジピンは主に高血圧の治療に用いられますが、狭心症の治療にも適応されることがあります。特に、変動性狭心症や労作性狭心症において、心筋への血液供給を改善するために使用されます。また、心不全や末梢血管障害など、他の循環器系の病状の軽減にも寄与することがあるため、広く処方されることがあります。

フェロジピンの副作用として、一般的には浮腫（むくみ）、頭痛、めまい、顔面紅潮などが報告されています。これらの副作用は、血管拡張作用により引き起こされることが多いです。また、心拍数の増加や、場合によっては心不全を悪化させる恐れもあるため、心疾患を抱える患者には注意が必要です。使用に際しては、医師の指導の下で適切な用量を守ることが重要です。

フェロジピンは、他の薬剤との併用療法にも利用されることが多いです。特に、ACE阻害薬や利尿剤などと併用することで、相乗的な抗高血圧作用を得ることができます。ただし、併用療法においては相互作用も考慮する必要があり、医師による慎重な管理が求められます。

近年の研究では、フェロジピンの抗炎症作用や内皮機能の改善効果についても注目されています。これにより、単なる血圧降下だけでなく、動脈硬化の予防や心血管のリスク管理においても重要な役割を果たす可能性があります。さらに、新しい調査が進む中で、フェロジピンのさらなる適応症や利点が明らかになってくることが期待されます。

フェロジピンは製剤として、通常は持続性のある製品が多く、徐放性の錠剤として提供されることが一般的です。これにより、長時間にわたって効果を持続させることができ、患者の服薬コンプライアンス向上にも寄与します。また、服用のタイミングを患者にとって便利な方法で調整できるため、治療計画の柔軟性も考慮されています。

総じて、フェロジピンは高血圧や狭心症に対する効果的な治療選択肢であり、安定した長時間の作用を持つことから、多くの患者にとって有用な薬剤となっています。今後も、その効果や適応に関する研究が進むことが期待され、多様な症状の改善に寄与できる可能性があります。フェロジピンの使用に際しては、医療提供者との密接なコミュニケーションが必要であり、個々の患者に応じた適切な治療が大切です。

COVID-19のパンデミックにより、フェロジピンのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にフェロジピンの世界市場のxxx％を占める「純度98％」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「降圧薬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
フェロジピンの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのフェロジピン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

フェロジピンのグローバル主要企業には、Jinan Kehui Pharmaceutical Technology、Wockhardt、HEC Pharm、Hefei Lifeon Pharmaceutical、Jiangsu Lianhuan Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

フェロジピン市場は、種類と用途によって区分されます。世界のフェロジピン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度98％、純度99％

【用途別セグメント】
降圧薬、有機合成、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- フェロジピン製品概要
- 種類別市場（純度98％、純度99％）
- 用途別市場（降圧薬、有機合成、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のフェロジピン販売量予測2017-2028
- 世界のフェロジピン売上予測2017-2028
- フェロジピンの地域別販売量
- フェロジピンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別フェロジピン販売量
- 主要メーカー別フェロジピン売上
- 主要メーカー別フェロジピン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度98％、純度99％）
- フェロジピンの種類別販売量
- フェロジピンの種類別売上
- フェロジピンの種類別価格
・用途別市場規模（降圧薬、有機合成、その他）
- フェロジピンの用途別販売量
- フェロジピンの用途別売上
- フェロジピンの用途別価格
・北米市場
- 北米のフェロジピン市場規模（種類別、用途別）
- 主要国別のフェロジピン市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのフェロジピン市場規模（種類別、用途別）
- 主要国別のフェロジピン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のフェロジピン市場規模（種類別、用途別）
- 主要国別のフェロジピン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のフェロジピン市場規模（種類別、用途別）
- 主要国別のフェロジピン市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのフェロジピン市場規模（種類別、用途別）
- 主要国別のフェロジピン市場規模（トルコ、サウジアラビア）
・企業情報
Jinan Kehui Pharmaceutical Technology、Wockhardt、HEC Pharm、Hefei Lifeon Pharmaceutical、Jiangsu Lianhuan Pharmaceutical
・産業チェーン及び販売チャネル分析
- フェロジピンの産業チェーン分析
- フェロジピンの原材料
- フェロジピンの生産プロセス
- フェロジピンの販売及びマーケティング
- フェロジピンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- フェロジピンの産業動向
- フェロジピンのマーケットドライバー
- フェロジピンの課題
- フェロジピンの阻害要因
・主な調査結果

Market Analysis and Insights: Global Felodipine Market
Due to the COVID-19 pandemic, the global Felodipine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 98% Purity accounting for % of the Felodipine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Antihypertensive Drugs segment is altered to an % CAGR throughout this forecast period.
China Felodipine market size is valued at US$ million in 2021, while the US and Europe Felodipine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Felodipine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Felodipine include Jinan Kehui Pharmaceutical Technology, Wockhardt, HEC Pharm, Hefei Lifeon Pharmaceutical and Jiangsu Lianhuan Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Felodipine capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Felodipine by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Felodipine Scope and Segment
Felodipine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Felodipine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
98% Purity
99% Purity
Segment by Application
Antihypertensive Drugs
Organic Synthesis
Other
By Company
Jinan Kehui Pharmaceutical Technology
Wockhardt
HEC Pharm
Hefei Lifeon Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Felodipine Product Introduction
1.2 Market by Type
1.2.1 Global Felodipine Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 98% Purity
1.2.3 99% Purity
1.3 Market by Application
1.3.1 Global Felodipine Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Antihypertensive Drugs
1.3.3 Organic Synthesis
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Felodipine Production
2.1 Global Felodipine Production Capacity (2017-2028)
2.2 Global Felodipine Production by Region: 2017 VS 2021 VS 2028
2.3 Global Felodipine Production by Region
2.3.1 Global Felodipine Historic Production by Region (2017-2022)
2.3.2 Global Felodipine Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Felodipine Sales in Volume & Value Estimates and Forecasts
3.1 Global Felodipine Sales Estimates and Forecasts 2017-2028
3.2 Global Felodipine Revenue Estimates and Forecasts 2017-2028
3.3 Global Felodipine Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Felodipine Sales by Region
3.4.1 Global Felodipine Sales by Region (2017-2022)
3.4.2 Global Sales Felodipine by Region (2023-2028)
3.5 Global Felodipine Revenue by Region
3.5.1 Global Felodipine Revenue by Region (2017-2022)
3.5.2 Global Felodipine Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Felodipine Production Capacity by Manufacturers
4.2 Global Felodipine Sales by Manufacturers
4.2.1 Global Felodipine Sales by Manufacturers (2017-2022)
4.2.2 Global Felodipine Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Felodipine in 2021
4.3 Global Felodipine Revenue by Manufacturers
4.3.1 Global Felodipine Revenue by Manufacturers (2017-2022)
4.3.2 Global Felodipine Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Felodipine Revenue in 2021
4.4 Global Felodipine Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Felodipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Felodipine Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Felodipine Sales by Type
5.1.1 Global Felodipine Historical Sales by Type (2017-2022)
5.1.2 Global Felodipine Forecasted Sales by Type (2023-2028)
5.1.3 Global Felodipine Sales Market Share by Type (2017-2028)
5.2 Global Felodipine Revenue by Type
5.2.1 Global Felodipine Historical Revenue by Type (2017-2022)
5.2.2 Global Felodipine Forecasted Revenue by Type (2023-2028)
5.2.3 Global Felodipine Revenue Market Share by Type (2017-2028)
5.3 Global Felodipine Price by Type
5.3.1 Global Felodipine Price by Type (2017-2022)
5.3.2 Global Felodipine Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Felodipine Sales by Application
6.1.1 Global Felodipine Historical Sales by Application (2017-2022)
6.1.2 Global Felodipine Forecasted Sales by Application (2023-2028)
6.1.3 Global Felodipine Sales Market Share by Application (2017-2028)
6.2 Global Felodipine Revenue by Application
6.2.1 Global Felodipine Historical Revenue by Application (2017-2022)
6.2.2 Global Felodipine Forecasted Revenue by Application (2023-2028)
6.2.3 Global Felodipine Revenue Market Share by Application (2017-2028)
6.3 Global Felodipine Price by Application
6.3.1 Global Felodipine Price by Application (2017-2022)
6.3.2 Global Felodipine Price Forecast by Application (2023-2028)
7 North America
7.1 North America Felodipine Market Size by Type
7.1.1 North America Felodipine Sales by Type (2017-2028)
7.1.2 North America Felodipine Revenue by Type (2017-2028)
7.2 North America Felodipine Market Size by Application
7.2.1 North America Felodipine Sales by Application (2017-2028)
7.2.2 North America Felodipine Revenue by Application (2017-2028)
7.3 North America Felodipine Sales by Country
7.3.1 North America Felodipine Sales by Country (2017-2028)
7.3.2 North America Felodipine Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Felodipine Market Size by Type
8.1.1 Europe Felodipine Sales by Type (2017-2028)
8.1.2 Europe Felodipine Revenue by Type (2017-2028)
8.2 Europe Felodipine Market Size by Application
8.2.1 Europe Felodipine Sales by Application (2017-2028)
8.2.2 Europe Felodipine Revenue by Application (2017-2028)
8.3 Europe Felodipine Sales by Country
8.3.1 Europe Felodipine Sales by Country (2017-2028)
8.3.2 Europe Felodipine Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Felodipine Market Size by Type
9.1.1 Asia Pacific Felodipine Sales by Type (2017-2028)
9.1.2 Asia Pacific Felodipine Revenue by Type (2017-2028)
9.2 Asia Pacific Felodipine Market Size by Application
9.2.1 Asia Pacific Felodipine Sales by Application (2017-2028)
9.2.2 Asia Pacific Felodipine Revenue by Application (2017-2028)
9.3 Asia Pacific Felodipine Sales by Region
9.3.1 Asia Pacific Felodipine Sales by Region (2017-2028)
9.3.2 Asia Pacific Felodipine Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Felodipine Market Size by Type
10.1.1 Latin America Felodipine Sales by Type (2017-2028)
10.1.2 Latin America Felodipine Revenue by Type (2017-2028)
10.2 Latin America Felodipine Market Size by Application
10.2.1 Latin America Felodipine Sales by Application (2017-2028)
10.2.2 Latin America Felodipine Revenue by Application (2017-2028)
10.3 Latin America Felodipine Sales by Country
10.3.1 Latin America Felodipine Sales by Country (2017-2028)
10.3.2 Latin America Felodipine Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Felodipine Market Size by Type
11.1.1 Middle East and Africa Felodipine Sales by Type (2017-2028)
11.1.2 Middle East and Africa Felodipine Revenue by Type (2017-2028)
11.2 Middle East and Africa Felodipine Market Size by Application
11.2.1 Middle East and Africa Felodipine Sales by Application (2017-2028)
11.2.2 Middle East and Africa Felodipine Revenue by Application (2017-2028)
11.3 Middle East and Africa Felodipine Sales by Country
11.3.1 Middle East and Africa Felodipine Sales by Country (2017-2028)
11.3.2 Middle East and Africa Felodipine Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Jinan Kehui Pharmaceutical Technology
12.1.1 Jinan Kehui Pharmaceutical Technology Corporation Information
12.1.2 Jinan Kehui Pharmaceutical Technology Overview
12.1.3 Jinan Kehui Pharmaceutical Technology Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Jinan Kehui Pharmaceutical Technology Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Jinan Kehui Pharmaceutical Technology Recent Developments
12.2 Wockhardt
12.2.1 Wockhardt Corporation Information
12.2.2 Wockhardt Overview
12.2.3 Wockhardt Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Wockhardt Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Wockhardt Recent Developments
12.3 HEC Pharm
12.3.1 HEC Pharm Corporation Information
12.3.2 HEC Pharm Overview
12.3.3 HEC Pharm Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 HEC Pharm Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 HEC Pharm Recent Developments
12.4 Hefei Lifeon Pharmaceutical
12.4.1 Hefei Lifeon Pharmaceutical Corporation Information
12.4.2 Hefei Lifeon Pharmaceutical Overview
12.4.3 Hefei Lifeon Pharmaceutical Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Hefei Lifeon Pharmaceutical Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hefei Lifeon Pharmaceutical Recent Developments
12.5 Jiangsu Lianhuan Pharmaceutical
12.5.1 Jiangsu Lianhuan Pharmaceutical Corporation Information
12.5.2 Jiangsu Lianhuan Pharmaceutical Overview
12.5.3 Jiangsu Lianhuan Pharmaceutical Felodipine Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Jiangsu Lianhuan Pharmaceutical Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Jiangsu Lianhuan Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Felodipine Industry Chain Analysis
13.2 Felodipine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Felodipine Production Mode & Process
13.4 Felodipine Sales and Marketing
13.4.1 Felodipine Sales Channels
13.4.2 Felodipine Distributors
13.5 Felodipine Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Felodipine Industry Trends
14.2 Felodipine Market Drivers
14.3 Felodipine Market Challenges
14.4 Felodipine Market Restraints
15 Key Finding in The Global Felodipine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Felodipine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 98% Purity
Table 3. Major Manufacturers of 99% Purity
Table 4. Global Felodipine Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Felodipine Production by Region: 2017 VS 2021 VS 2028 (MT)
Table 6. Global Felodipine Production by Region (2017-2022) & (MT)
Table 7. Global Felodipine Production Market Share by Region (2017-2022)
Table 8. Global Felodipine Production by Region (2023-2028) & (MT)
Table 9. Global Felodipine Production Market Share by Region (2023-2028)
Table 10. Global Felodipine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Felodipine Sales by Region (2017-2022) & (MT)
Table 12. Global Felodipine Sales Market Share by Region (2017-2022)
Table 13. Global Felodipine Sales by Region (2023-2028) & (MT)
Table 14. Global Felodipine Sales Market Share by Region (2023-2028)
Table 15. Global Felodipine Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Felodipine Revenue Market Share by Region (2017-2022)
Table 17. Global Felodipine Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Felodipine Revenue Market Share by Region (2023-2028)
Table 19. Global Felodipine Production Capacity by Manufacturers (2017-2022) & (MT)
Table 20. Global Felodipine Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Felodipine Sales by Manufacturers (2017-2022) & (MT)
Table 22. Global Felodipine Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Felodipine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Felodipine Revenue Share by Manufacturers (2017-2022)
Table 25. Felodipine Price by Manufacturers 2017-2022 (USD/MT)
Table 26. Global Felodipine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Felodipine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Felodipine as of 2021)
Table 28. Felodipine Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Felodipine Product Offered
Table 30. Date of Manufacturers Enter into Felodipine Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Felodipine Sales by Type (2017-2022) & (MT)
Table 33. Global Felodipine Sales by Type (2023-2028) & (MT)
Table 34. Global Felodipine Sales Share by Type (2017-2022)
Table 35. Global Felodipine Sales Share by Type (2023-2028)
Table 36. Global Felodipine Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Felodipine Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Felodipine Revenue Share by Type (2017-2022)
Table 39. Global Felodipine Revenue Share by Type (2023-2028)
Table 40. Felodipine Price by Type (2017-2022) & (USD/MT)
Table 41. Global Felodipine Price Forecast by Type (2023-2028) & (USD/MT)
Table 42. Global Felodipine Sales by Application (2017-2022) & (MT)
Table 43. Global Felodipine Sales by Application (2023-2028) & (MT)
Table 44. Global Felodipine Sales Share by Application (2017-2022)
Table 45. Global Felodipine Sales Share by Application (2023-2028)
Table 46. Global Felodipine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Felodipine Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Felodipine Revenue Share by Application (2017-2022)
Table 49. Global Felodipine Revenue Share by Application (2023-2028)
Table 50. Felodipine Price by Application (2017-2022) & (USD/MT)
Table 51. Global Felodipine Price Forecast by Application (2023-2028) & (USD/MT)
Table 52. North America Felodipine Sales by Type (2017-2022) & (MT)
Table 53. North America Felodipine Sales by Type (2023-2028) & (MT)
Table 54. North America Felodipine Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Felodipine Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Felodipine Sales by Application (2017-2022) & (MT)
Table 57. North America Felodipine Sales by Application (2023-2028) & (MT)
Table 58. North America Felodipine Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Felodipine Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Felodipine Sales by Country (2017-2022) & (MT)
Table 61. North America Felodipine Sales by Country (2023-2028) & (MT)
Table 62. North America Felodipine Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Felodipine Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Felodipine Sales by Type (2017-2022) & (MT)
Table 65. Europe Felodipine Sales by Type (2023-2028) & (MT)
Table 66. Europe Felodipine Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Felodipine Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Felodipine Sales by Application (2017-2022) & (MT)
Table 69. Europe Felodipine Sales by Application (2023-2028) & (MT)
Table 70. Europe Felodipine Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Felodipine Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Felodipine Sales by Country (2017-2022) & (MT)
Table 73. Europe Felodipine Sales by Country (2023-2028) & (MT)
Table 74. Europe Felodipine Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Felodipine Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Felodipine Sales by Type (2017-2022) & (MT)
Table 77. Asia Pacific Felodipine Sales by Type (2023-2028) & (MT)
Table 78. Asia Pacific Felodipine Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Felodipine Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Felodipine Sales by Application (2017-2022) & (MT)
Table 81. Asia Pacific Felodipine Sales by Application (2023-2028) & (MT)
Table 82. Asia Pacific Felodipine Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Felodipine Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Felodipine Sales by Region (2017-2022) & (MT)
Table 85. Asia Pacific Felodipine Sales by Region (2023-2028) & (MT)
Table 86. Asia Pacific Felodipine Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Felodipine Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Felodipine Sales by Type (2017-2022) & (MT)
Table 89. Latin America Felodipine Sales by Type (2023-2028) & (MT)
Table 90. Latin America Felodipine Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Felodipine Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Felodipine Sales by Application (2017-2022) & (MT)
Table 93. Latin America Felodipine Sales by Application (2023-2028) & (MT)
Table 94. Latin America Felodipine Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Felodipine Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Felodipine Sales by Country (2017-2022) & (MT)
Table 97. Latin America Felodipine Sales by Country (2023-2028) & (MT)
Table 98. Latin America Felodipine Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Felodipine Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Felodipine Sales by Type (2017-2022) & (MT)
Table 101. Middle East and Africa Felodipine Sales by Type (2023-2028) & (MT)
Table 102. Middle East and Africa Felodipine Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Felodipine Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Felodipine Sales by Application (2017-2022) & (MT)
Table 105. Middle East and Africa Felodipine Sales by Application (2023-2028) & (MT)
Table 106. Middle East and Africa Felodipine Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Felodipine Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Felodipine Sales by Country (2017-2022) & (MT)
Table 109. Middle East and Africa Felodipine Sales by Country (2023-2028) & (MT)
Table 110. Middle East and Africa Felodipine Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Felodipine Revenue by Country (2023-2028) & (US$ Million)
Table 112. Jinan Kehui Pharmaceutical Technology Corporation Information
Table 113. Jinan Kehui Pharmaceutical Technology Description and Major Businesses
Table 114. Jinan Kehui Pharmaceutical Technology Felodipine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Jinan Kehui Pharmaceutical Technology Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Jinan Kehui Pharmaceutical Technology Recent Development
Table 117. Wockhardt Corporation Information
Table 118. Wockhardt Description and Major Businesses
Table 119. Wockhardt Felodipine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. Wockhardt Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Wockhardt Recent Development
Table 122. HEC Pharm Corporation Information
Table 123. HEC Pharm Description and Major Businesses
Table 124. HEC Pharm Felodipine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. HEC Pharm Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. HEC Pharm Recent Development
Table 127. Hefei Lifeon Pharmaceutical Corporation Information
Table 128. Hefei Lifeon Pharmaceutical Description and Major Businesses
Table 129. Hefei Lifeon Pharmaceutical Felodipine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Hefei Lifeon Pharmaceutical Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Hefei Lifeon Pharmaceutical Recent Development
Table 132. Jiangsu Lianhuan Pharmaceutical Corporation Information
Table 133. Jiangsu Lianhuan Pharmaceutical Description and Major Businesses
Table 134. Jiangsu Lianhuan Pharmaceutical Felodipine Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Jiangsu Lianhuan Pharmaceutical Felodipine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Jiangsu Lianhuan Pharmaceutical Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Felodipine Distributors List
Table 140. Felodipine Customers List
Table 141. Felodipine Market Trends
Table 142. Felodipine Market Drivers
Table 143. Felodipine Market Challenges
Table 144. Felodipine Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Felodipine Product Picture
Figure 2. Global Felodipine Market Share by Type in 2021 & 2028
Figure 3. 98% Purity Product Picture
Figure 4. 99% Purity Product Picture
Figure 5. Global Felodipine Market Share by Application in 2021 & 2028
Figure 6. Antihypertensive Drugs
Figure 7. Organic Synthesis
Figure 8. Other
Figure 9. Felodipine Report Years Considered
Figure 10. Global Felodipine Capacity, Production and Utilization (2017-2028) & (MT)
Figure 11. Global Felodipine Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Felodipine Production Market Share by Region (2017-2022)
Figure 13. Global Felodipine Production Market Share by Region (2023-2028)
Figure 14. Felodipine Production Growth Rate in North America (2017-2028) & (MT)
Figure 15. Felodipine Production Growth Rate in Europe (2017-2028) & (MT)
Figure 16. Felodipine Production Growth Rate in China (2017-2028) & (MT)
Figure 17. Felodipine Production Growth Rate in Japan (2017-2028) & (MT)
Figure 18. Global Felodipine Sales 2017-2028 (MT)
Figure 19. Global Felodipine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Felodipine Revenue 2017-2028 (US$ Million)
Figure 21. Global Felodipine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 22. Global Felodipine Sales Market Share by Region (2017-2022)
Figure 23. Global Felodipine Sales Market Share by Region (2023-2028)
Figure 24. North America Felodipine Sales YoY (2017-2028) & (MT)
Figure 25. North America Felodipine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Europe Felodipine Sales YoY (2017-2028) & (MT)
Figure 27. Europe Felodipine Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Felodipine Sales YoY (2017-2028) & (MT)
Figure 29. Asia-Pacific Felodipine Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Latin America Felodipine Sales YoY (2017-2028) & (MT)
Figure 31. Latin America Felodipine Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Middle East & Africa Felodipine Sales YoY (2017-2028) & (MT)
Figure 33. Middle East & Africa Felodipine Revenue YoY (2017-2028) & (US$ Million)
Figure 34. The Felodipine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 35. The Top 5 and 10 Largest Manufacturers of Felodipine in the World: Market Share by Felodipine Revenue in 2021
Figure 36. Felodipine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 37. Global Felodipine Sales Market Share by Type (2017-2028)
Figure 38. Global Felodipine Revenue Market Share by Type (2017-2028)
Figure 39. Global Felodipine Sales Market Share by Application (2017-2028)
Figure 40. Global Felodipine Revenue Market Share by Application (2017-2028)
Figure 41. North America Felodipine Sales Market Share by Type (2017-2028)
Figure 42. North America Felodipine Revenue Market Share by Type (2017-2028)
Figure 43. North America Felodipine Sales Market Share by Application (2017-2028)
Figure 44. North America Felodipine Revenue Market Share by Application (2017-2028)
Figure 45. North America Felodipine Sales Share by Country (2017-2028)
Figure 46. North America Felodipine Revenue Share by Country (2017-2028)
Figure 47. United States Felodipine Revenue (2017-2028) & (US$ Million)
Figure 48. Canada Felodipine Revenue (2017-2028) & (US$ Million)
Figure 49. Europe Felodipine Sales Market Share by Type (2017-2028)
Figure 50. Europe Felodipine Revenue Market Share by Type (2017-2028)
Figure 51. Europe Felodipine Sales Market Share by Application (2017-2028)
Figure 52. Europe Felodipine Revenue Market Share by Application (2017-2028)
Figure 53. Europe Felodipine Sales Share by Country (2017-2028)
Figure 54. Europe Felodipine Revenue Share by Country (2017-2028)
Figure 55. Germany Felodipine Revenue (2017-2028) & (US$ Million)
Figure 56. France Felodipine Revenue (2017-2028) & (US$ Million)
Figure 57. U.K. Felodipine Revenue (2017-2028) & (US$ Million)
Figure 58. Italy Felodipine Revenue (2017-2028) & (US$ Million)
Figure 59. Russia Felodipine Revenue (2017-2028) & (US$ Million)
Figure 60. Asia Pacific Felodipine Sales Market Share by Type (2017-2028)
Figure 61. Asia Pacific Felodipine Revenue Market Share by Type (2017-2028)
Figure 62. Asia Pacific Felodipine Sales Market Share by Application (2017-2028)
Figure 63. Asia Pacific Felodipine Revenue Market Share by Application (2017-2028)
Figure 64. Asia Pacific Felodipine Sales Share by Region (2017-2028)
Figure 65. Asia Pacific Felodipine Revenue Share by Region (2017-2028)
Figure 66. China Felodipine Revenue (2017-2028) & (US$ Million)
Figure 67. Japan Felodipine Revenue (2017-2028) & (US$ Million)
Figure 68. South Korea Felodipine Revenue (2017-2028) & (US$ Million)
Figure 69. India Felodipine Revenue (2017-2028) & (US$ Million)
Figure 70. Australia Felodipine Revenue (2017-2028) & (US$ Million)
Figure 71. Taiwan Felodipine Revenue (2017-2028) & (US$ Million)
Figure 72. Indonesia Felodipine Revenue (2017-2028) & (US$ Million)
Figure 73. Thailand Felodipine Revenue (2017-2028) & (US$ Million)
Figure 74. Malaysia Felodipine Revenue (2017-2028) & (US$ Million)
Figure 75. Latin America Felodipine Sales Market Share by Type (2017-2028)
Figure 76. Latin America Felodipine Revenue Market Share by Type (2017-2028)
Figure 77. Latin America Felodipine Sales Market Share by Application (2017-2028)
Figure 78. Latin America Felodipine Revenue Market Share by Application (2017-2028)
Figure 79. Latin America Felodipine Sales Share by Country (2017-2028)
Figure 80. Latin America Felodipine Revenue Share by Country (2017-2028)
Figure 81. Mexico Felodipine Revenue (2017-2028) & (US$ Million)
Figure 82. Brazil Felodipine Revenue (2017-2028) & (US$ Million)
Figure 83. Argentina Felodipine Revenue (2017-2028) & (US$ Million)
Figure 84. Colombia Felodipine Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa Felodipine Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Felodipine Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Felodipine Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Felodipine Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Felodipine Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa Felodipine Revenue Share by Country (2017-2028)
Figure 91. Turkey Felodipine Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia Felodipine Revenue (2017-2028) & (US$ Million)
Figure 93. UAE Felodipine Revenue (2017-2028) & (US$ Million)
Figure 94. Felodipine Value Chain
Figure 95. Felodipine Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のフェロジピン市場インサイト及び予測（純度98％、純度99％）(Global Felodipine Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のフェロジピン市場インサイト及び予測（純度98％、純度99％）

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp